In addition, such doses were associated with a ‘near-significant’ 17 percent decrease in the risk of ‘total fatal coronary events’, according to a team of researchers from academia and industry.
Search
News Archive
Categories
algae
alternative energy
aquaculture
Aquapharm
Aquapreneur
astaxanthin
biofuel
biomaterials
bioprocessing
brown seaweed
chitin
chitosan
commercialize
cosmeceuticals
cosmetics
DHA
EPA
fish oil
fish protein
fucoidans
functional food
functional ingredients
glycomar
krill oil
marine biopolymer
marine bioprospecting
marine biotech cluster
marine biotechnology
marine drugs
marine enzymes
marine extract
marine ingredient
marine ingredients
marine microbe
marine natural product
marine organism
marine protein
microalgae
nutraceutical
omega 3
pharmaceutical
seafood byproducts
seaweed
sustainable
technology
Solazyme Expands Algenist Distribution Channels to Include Sephora Canada and The Shopping Channel
Posted On: July 7, 2011Solazyme, Inc. a renewable oil and bioproducts company, has signed agreements with Sephora Canada and the leading Canadian multimedia retailer, The Shopping Channel®, to launch Algenist™, Solazyme’s microalgae-based prestige anti-aging skincare line throughout the country. In an unprecedented beauty launch that couples world-class biotechnology with Canada’s most prominent beauty retailers, the Algenist product line will begin selling in all 26 Canadian Sephora stores and on The Shopping Channel’s highest rated beauty programming starting in July 2011.
Algenist is a product line of advanced anti-aging skincare products formulated with Solazyme’s breakthrough ingredient, alguronic acid, an unexpected discovery which was found by the company’s leading biotechnology scientists while researching microalgae for renewable energy solutions. When studied for potential anti-aging benefits, alguronic acid demonstrated significant results and outperformed some of the most well known anti-aging ingredients on the market including hyaluronic acid, retinol and vitamins C and E.
“Algenist comes from a lineage of biotechnology expertise that is not only pioneering the future of skincare, but reinvigorated the luxury skin and personal care space,” said Frederic Stoeckel, Senior Vice President & General Manager, Solazyme Health Sciences. “Sephora and The Shopping Channel provide incredible support and access to some of the largest markets in the world and we look forward to a successful launch with their respective audiences in Canada.”
From Issue 15 • Categories: Tags: algae, Algenist, Aquapreneur, cosmeceuticals, functional ingredients, marine extract, marine ingredients, microalgae, seaweed, Solazyme • No Comments
Fish enzymes show potential to boost dairy flavors: Study
Posted On: June 14, 2011Enzymes from salmon and hoki may enhance the flavor profile of dairy products, like specialty cheeses, suggests a study from Canada and New Zealand.
Digestive enzymes are used to speed up the ripening of dairy products such as cheeses, and play an important role in the development of the finished products flavor. Many such enzymes – called pregastric esterase (PGE) or pregastric lipase – are obtained from ruminants, like calves or lambs.
According to new data published in Food Chemistry, digestive enzymes from fish such as salmon and hoki may also be used to produce desirable flavor profiles in dairy products.
The enzymes from these fish may also offer technological benefits, by being able to function at considerably lower temperatures than enzymes obtained from other fish or mammals, explained researchers from McGill University and The New Zealand Institute for Plant and Food Research Limited.
Such a characteristic, suggested the researchers, “could make the enzymes suitable for applications such as the hydrolysis of milk fat, release of FAs and flavor volatiles, desired in specialty cheeses and other ‘ripened’ dairy products”.
Marine MUFAs may improve metabolic syndrome: Mouse study
Posted On: June 14, 2011Long-chain monounsaturated fatty acids from fish sources may improve insulin sensitivity and reduce risk factors associated with metabolic syndrome, according to new research in mice.
The study, published in the Journal of Agricultural and Food Chemistry, reports that blood plasma glucose, insulin, and lipid concentrations are enhanced, whilst insulin sensitivity is improved in mice fed a diet rich in marine derived long-chain monounsaturated fatty acids (MUFAs).
“This study demonstrates that fish-oil-derived MUFA ingestion reduces insulin resistance, as judged by the insulin tolerance test, and attenuates metabolic syndrome by improving hyperglycemia, hyperinsulinemia, and hyperlipidemia,” wrote the study authors, led by Zhi-Hong Yang, from the Tokyo Innovation Center, Japan.
“Furthermore, intake of MUFA decreased obesity-induced inflammation by suppressing … inflammatory marker genes and arachidonic acid levels, thereby possibly, in turn, reducing insulin resistance in diet-induced obese mice,” they added.
From Issue 14 • Categories: Tags: Aquapreneur, blood plasma glucose, DHA, EPA, fish oil, fish protein, functional ingredients, marine extract, marine ingredients, MUFA, Tokyo Innovation Center • No Comments
New Astec Centre in UK to offer new opportunities for fledgling marine businesses
Posted On: June 2, 2011The recent opening of the Astec Centre is expected to offer a number of opportunities for fledgling marine businesses.
Astec Aquaculture Business & Science Centre is a purpose-built resource that has been created to support the growth of the aquaculture sector. It opened its doors to businesses and researchers recently, showcasing the extensive facilities and support services that it offers.
Due to its strategic location on the Northumberland coastline at Lyne Sands, Astec is uniquely placed to pump a constant supply of near tropical temperature, flow-through seawater to its state-of-the-art aqua laboratories, which are fitted out with specialist equipment to support a broad range of commercial and research activities.
The new Astec Centre is located close by the Dove Marine Laboratory at Newcastle University, considered a key centre for Newcastle University’s School of Marine Science and Technology, which is leading research into areas such as algae biofuels. However, the prospect of state-of-the-art facilities nearby could help experts refine and expand discoveries further.
Dove Marine Laboratory director Professor Grant Burgess said: “We have several early-stage projects which we may be able to commercialise over the next 12 months. These involve growing and harvesting marine microalgae to make useful products such as omega 3 oils. Astec offers the expertise, historical track record and passion of the people involved to ensure this project is a success.”
The focus at the centre is on application of marine science to building businesses and creating jobs. This complements and builds on current marine biotechnology programmes at the Dove and will considerably strengthen the region in this growth area.
e info
From Issue 14 • Categories: Tags: algae, algae biofuels, aquaculture, Aquapreneur, Astec Centre, bioprocessing, commercialize, Dove Marine Laboratory, functional ingredients, marine bioprospecting, marine biotechnology, marine extract, marine ingredient, Newcastle University, School of Marine Science and Technology, seafood byproducts • No Comments
Dose threshold for omega-3 heart benefits studied
Posted On: June 2, 2011Daily doses of omega-3s of at least 250 milligrams are required to reduce the risk of sudden cardiac death and other heart conditions, says a new review and meta-analysis.
According to findings published in the British Journal of Nutrition, at least 250 mg of the long-chain omega-3 fatty acids (LCFA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), was associated with a 35 percent reduction in the risk of sudden cardiac death.
From Issue 14 • Categories: Tags: Aquapreneur, DHA, EPA, fish oil, marine biotechnology, marine extract, marine ingredient, marine ingredients, nutraceutical, omega 3, seafood byproducts • No Comments
Genome of Marine Organism Reveals Hidden Secrets
Posted On: May 13, 2011An international team of researchers led by scientists at Scripps Institution of Oceanography at UC San Diego has deciphered the genome of a tropical marine organism known to produce substances potentially useful against human diseases.
Tiny photosynthetic microorganisms called cyanobacteria are some of the oldest forms of life on the planet. At times their emergence as toxic blooms causes a threat to humans and animals. But despite the recognized capability of marine strains of the cyanobacterial genus Lyngbya, and specifically the species L. majuscula, to create hundreds of natural products with biomedical promise, surprisingly little is known about the genetics underlying their production.
In this week’s online early edition of the Proceedings of the National Academy of Sciences, a research team led by Scripps graduate student Adam Jones and postdoctoral fellow Emily Monroe, both in the Gerwick laboratory at Scripps Institution of Oceanography’s Center for Marine Biotechnology and Biomedicine (CMBB), provide the first insights of the genome of Lyngbya majuscula 3L, a Caribbean organism that generates compounds that are being developed for potential treatment against cancer and neurodegenerative diseases.
From Issue 14 • Categories: Tags: Aquapreneur, L. majuscula, marine bioprospecting, marine biotechnology, marine drugs, marine extract, marine ingredients, marine natural product, Proceedings of the National Academy of Sciences, Scripps Institution of Oceanography, Scripps Institution of Oceanography's Center for Marine Biotechnology and Biomedicine • No Comments
Astaxanthin shows benefits for obese health
Posted On: May 6, 2011Daily supplements containing astaxanthin, the pink pigment that gives salmon its color, may boost the body’s antioxidants defenses in obese people, says a new study from South Korea.
Researchers from Seoul National University report that daily doses of 5 or 20 milligrams of astaxanthin for three weeks were associated with increases in levels of the body’s own antioxidant defenses, as well as decreases in levels of oxidative species.
“Although these data show that astaxanthin is protective against obesity‐induced oxidative stress, a longer term study with a larger sample size should be conducted to establish whether astaxanthin supplementation can consistently and permanently reduce oxidative stress levels,” wrote the researchers in Phytotherapy Research.
From Issue 14 • Categories: Tags: algae, Aquapreneur, astaxanthin, marine extract, marine ingredient, marine ingredients, microalgae, obesity, oxidative stress, seafood byproducts • No Comments
New Marine Drugs Issue Available
Posted On: April 6, 2011New publication from www.mdpi.com.
Marine Drugs
First Evidence of Palytoxin and 42-Hydroxy-palytoxin in the Marine Cyanobacterium Trichodesmium
Mar. Drugs 2011, 9(4), 543-560; doi:10.3390/md9040543
http://www.mdpi.com/1660-3397/9/4/543/
Published online: 31 March 2011
Effects of High Salt Stress on Secondary Metabolite Production in the Marine-Derived Fungus Spicaria elegans
Mar. Drugs 2011, 9(4), 535-542; doi:10.3390/md9040535
http://www.mdpi.com/1660-3397/9/4/535/
Published online: 31 March 2011
The Acute Toxicity and Hematological Characterization of the Effects of Tentacle-Only Extract from the Jellyfish Cyanea capillata
Mar. Drugs 2011, 9(4), 526-534; doi:10.3390/md9040526
http://www.mdpi.com/1660-3397/9/4/526/
Published online: 29 March 2011
Statistical Research on Marine Natural Products Based on Data Obtained between 1985 and 2008
Mar. Drugs 2011, 9(4), 514-525; doi:10.3390/md9040514
http://www.mdpi.com/1660-3397/9/4/514/
Published online: 29 March 2011
Quantification of Dissolved and Particulate Polyunsaturated Aldehydes in the Adriatic Sea
Mar. Drugs 2011, 9(4), 500-513; doi:10.3390/md9040500
http://www.mdpi.com/1660-3397/9/4/500/
Published online: 29 March 2011
From Issue 14 • Categories: Tags: Aquapreneur, marine biotechnology, marine drugs, marine extract, marine natural product, MDPI, nutraceutical, pharmaceutical • No Comments
Calamari-derived omega-3 achieves European Novel Foods Approval
Posted On: March 16, 2011The European Union has recently approved for commercialization Pharma Marine’s Calamarine line of responsibly sourced, high docosahexaenoic acid (DHA) Omega-3 ingredients. Derived from the byproducts of food-grade calamari (Cephalopoda), Calamarine Omega-3 oils offer a high quality alternative to potentially overexploited fish species often used in the manufacture of high DHA Omega-3 products.
On behalf of the European Food Safety Authority, the General Chemical State Laboratory in Athens, Greece has determined that Calamarine ingredients are the substantial equivalent of tuna-derived omega-3. Further, the investigators found that heavy metals, pesticides, dioxins, and other toxins in Calamarine were well within safe levels as established by European Union Commission Regulations.
Commenting on the European Union decision, company R&D Director and Omega-3 industry veteran Asgeir Saebo stated, “We are very pleased that the European Food Safety Authority, after evaluating the scientific literature, toxicology analysis, and data on the fatty acid profile, has unanimously approved Calamarine for EU market entry. I expect that the health benefits from high DHA Calamarine oil will be superior to the typical marine-derived EPA omega-3 products. After all, DHA accounts for more than 90% of the omega-3 in the human eyes and brain and more than 70% of the omega-3 in blood and heart tissue.”
From Issue 13 • Categories: Tags: Aquapreneur, calamari, Calamarine, Cephalopoda, DHA, EPA, fish oil, functional ingredients, marine extract, marine ingredient, marine ingredients, marine lipid, nutraceutical, omega 3 • No Comments
Solazyme, Sephora and QVC Announce Agreements for the U.S. and International Launch of Solazyme’s New Anti-Aging Skincare Line, Algenist™
Posted On: March 9, 2011Solazyme, Inc., the leading industrial biotechnology company producing renewable oil and bioproducts from microalgae, has signed agreements with leading beauty retailer Sephora® and leading global multimedia retailer QVC® to launch Algenist™, Solazyme’s microalgae-based prestige anti-aging skincare line, in the U.S. and internationally. Beginning in March 2011, Algenist will be available on QVC in the U.S. and in over 800 Sephora stores in seven countries throughout Europe and in the US before expanding to Asia and the Middle East. Sephora and QVC will align their powerful promotional efforts behind Algenist in an unprecedented launch.
“We are constantly looking for the latest groundbreaking products to debut to our beauty customer who is both an early adopter and a beauty enthusiast. Algenist is the perfect addition to our growing assortment of premium beauty products.”
Algenist is a line of advanced anti-aging skincare products formulated with Solazyme’s breakthrough ingredient, alguronic acid. Solazyme’s biotechnology scientists unexpectedly discovered alguronic acid, a true breakthrough in the anti-aging market, after studying thousands of microalgae strains for renewable energy solutions. When researched for potential anti-aging benefits, alguronic acid demonstrated significant rejuvenating properties.
From Issue 13 • Categories: Tags: algae, Algenist, alguronic acid, Aquapreneur, Commercialization, commercialize, cosmeceuticals, marine biotechnology, marine extract, marine ingredients, Solazyme • No Comments
Host
 |
Partners
  |
Sponsors
 |
 |
Share Aquapreneur
